Literature DB >> 17589805

Stevens-Johnson syndrome in children receiving phenobarbital therapy and cranial radiotherapy.

Antonio Ruggiero1, Paola Sabrina Buonuomo, Palma Maurizi, Maria Giuseppina Cefalo, Maria Pia Cefalo, Mirta Corsello, Riccardo Riccardi.   

Abstract

Stevens-Johnson syndrome (SJS) is a severe cutaneous eruption that most often appears as an adverse reaction to medication. In this report, we present two children with brain tumour who developed SJS while receiving cranial irradiation and anticonvulsant therapy with phenobarbital. Concomitant application of these two therapies may play an important role in the occurrence of the disease.

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17589805     DOI： 10.1007/s11060-007-9399-y

Source DB:  PubMed          Journal:  J Neurooncol        ISSN： 0167-594X            Impact factor:   4.130


  14 in total

1.  Practice parameter: anticonvulsant prophylaxis in patients with newly diagnosed brain tumors. Report of the Quality Standards Subcommittee of the American Academy of Neurology.

Authors:  M J Glantz; B F Cole; P A Forsyth; L D Recht; P Y Wen; M C Chamberlain; S A Grossman; J G Cairncross
Journal:  Neurology       Date:  2000-05-23       Impact factor: 9.910

2.  Stevens-Johnson syndrome in two patients treated with cranial irradiation and phenytoin.

Authors:  F Aydin; C Cokluk; N Senturk; K Aydin; M T Canturk; A Y Turanli
Journal:  J Eur Acad Dermatol Venereol       Date:  2006-05       Impact factor: 6.166

3.  Stevens-Johnson syndrome in a patient receiving anticonvulsant therapy during cranial irradiation.

Authors:  Y Eralp; A Aydiner; F Taş; P Saip; E Topuz
Journal:  Am J Clin Oncol       Date:  2001-08       Impact factor: 2.339

4.  Risk of Stevens-Johnson syndrome and toxic epidermal necrolysis during first weeks of antiepileptic therapy: a case-control study. Study Group of the International Case Control Study on Severe Cutaneous Adverse Reactions.

Authors:  B Rzany; O Correia; J P Kelly; L Naldi; A Auquier; R Stern
Journal:  Lancet       Date:  1999-06-26       Impact factor: 79.321

5.  EMPACT syndrome.

Authors:  Stefan Wöhrl; Robert Loewe; Winfried F Pickl; Georg Stingl; Stephan N Wagner
Journal:  J Dtsch Dermatol Ges       Date:  2005-01       Impact factor: 5.584

Review 6.  [Stevens-Johnson syndrome, toxic epidermal necrolysis and phenytoin. Factors linked to a higher risk].

Authors:  M S Gómez-Criado; I Ayani; T León-Colombo; M L Ramos; M J Reneses
Journal:  Rev Neurol       Date:  2004 Jun 1-15       Impact factor: 0.870

7.  Toxic epidermal necrolysis after cranial radiotherapy and phenytoin treatment.

Authors:  F Oner Dincbas; S Yörük; C Demirkesen; O Uzel; S Koca
Journal:  Onkologie       Date:  2004-08

8.  Toxic epidermal necrolysis in patients receiving anticonvulsants and cranial irradiation: a risk to consider.

Authors:  David Aguiar; Roberto Pazo; Ignacio Durán; Josefa Terrasa; Antonio Arrivi; Herminio Manzano; Javier Martín; Julio Rifá
Journal:  J Neurooncol       Date:  2004-02       Impact factor: 4.130

9.  Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiforme.

Authors:  S Bastuji-Garin; B Rzany; R S Stern; N H Shear; L Naldi; J C Roujeau
Journal:  Arch Dermatol       Date:  1993-01

Review 10.  An international collaborative case-control study of severe cutaneous adverse reactions (SCAR). Design and methods.

Authors:  J P Kelly; A Auquier; B Rzany; L Naldi; S Bastuji-Garin; O Correia; S Shapiro; D W Kaufman
Journal:  J Clin Epidemiol       Date:  1995-09       Impact factor: 6.437
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.